Cargando…

Risk Model in Women with Ovarian Cancer Without Mutations

Ovarian cancer is characterised by the greatest mortality among all tumors of the reproductive tract. This study included 246 patients which consisted of 136 women with ovarian cancer without genetic mutation and 110 women with benign ovarian cysts. We created two mathematical logic models containin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cymbaluk-Płoska, Aneta, Chudecka-Głaz, Anita, Sompolska-Rzechuła, Agnieszka, Rasinska, Kamila, Dubiel, Paulina, Menkiszak, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272051/ https://www.ncbi.nlm.nih.gov/pubmed/30519634 http://dx.doi.org/10.1515/med-2018-0084

Ejemplares similares

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2014)

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Ectopic pregnancy treatment by combination therapy
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2016)

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2014)

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2015)

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018)

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017)

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department – the follow-up at 1 year
por: Nikodemski, Tomasz, et al.
Publicado: (2017)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016)

Anxiety Assessment in Polish Students during the Russian–Ukrainian War
por: Skwirczyńska, Edyta, et al.
Publicado: (2022)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
por: Menkiszak, Janusz, et al.
Publicado: (2019)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Evaluation of the Concentration of Selected Elements in Patients with Cancer of the Reproductive Organs with Respect to Treatment Stage—Preliminary Study
por: Wieder-Huszla, Sylwia, et al.
Publicado: (2022)

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
por: Mędrek, Krzysztof, et al.
Publicado: (2012)

Approaches to the Diagnosis and Management of Ovarian Cancer in Pregnancy
por: Michalczyk, Kaja, et al.
Publicado: (2021)

Assessment of the Development of Poverty in EU Countries
por: Sompolska-Rzechuła, Agnieszka, et al.
Publicado: (2022)

Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid
por: Kozłowski, Mateusz, et al.
Publicado: (2021)

The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors
por: Chudecka-Głaz, Anita, et al.
Publicado: (2013)

Psychological Associations of Stress with the Level of Health Locus of Control and Self-Efficacy in Patients with Ovarian Cancer
por: Skwirczyńska, Edyta, et al.
Publicado: (2023)

Long-Term Follow-Up of a Female Patient Treated with Olaparib—Hope for a Long Life without Relapse?
por: Kozłowski, Mateusz, et al.
Publicado: (2021)

Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021)

The Relationship between Social Support and Mental Health Problems of Peri- and Postmenopausal Women during the SARS-CoV-2 Pandemic
por: Cybulska, Anna Maria, et al.
Publicado: (2023)

The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer
por: Golara, Anna, et al.
Publicado: (2023)

Fertility Preservation and Long-Term Monitoring of Gonadotoxicity in Girls, Adolescents and Young Adults Undergoing Cancer Treatment
por: Michalczyk, Kaja, et al.
Publicado: (2021)

The Role of Zinc and Copper in Gynecological Malignancies
por: Michalczyk, Kaja, et al.
Publicado: (2020)

Metalloproteinases in Endometrial Cancer—Are They Worth Measuring?
por: Michalczyk, Kaja, et al.
Publicado: (2021)

Loneliness and the Degree of Addiction to Shopping and Work among Polish Women: The Mediating Role of Depression
por: Rachubińska, Kamila, et al.
Publicado: (2022)

Sexuality of Women after Gynecological Surgeries
por: Kozłowski, Mateusz, et al.
Publicado: (2020)

Endometrial Cancer Management in Young Women
por: Markowska, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mjrbuo3elpksgpaasqfaa5sqbc